Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: AVAPERL (MO22089)

F Barlesi; A Scherpenreel; A Rittmeyer; A Pazzola; N Ferrer Tur; Jung-Ha Kim; MJ Ahn; Joachim Aerts; V Gorbunova; A Vikstrom; EK Wong; P Perez-Moreno; L Mitchell; HJ Groen

doi:10.1200/jco.2012.42.3749

Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: AVAPERL (MO22089)

F Barlesi, A Scherpenreel, A Rittmeyer, A Pazzola, N Ferrer Tur, Jung-Ha Kim, MJ Ahn, Joachim Aerts, V Gorbunova, A Vikstrom, EK Wong, P Perez-Moreno, L Mitchell, HJ Groen

Pulmonary Medicine

Research output: Contribution to journal › Article › Academic › peer-review

267 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	3004-3011
Number of pages	8
Journal	Journal of Clinical Oncology
Volume	31
Issue number	24
DOIs	https://doi.org/10.1200/jco.2012.42.3749
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/jco.2012.42.3749

Cite this

Barlesi, F., Scherpenreel, A., Rittmeyer, A., Pazzola, A., Ferrer Tur, N., Kim, J-H., Ahn, MJ., Aerts, J., Gorbunova, V., Vikstrom, A., Wong, EK., Perez-Moreno, P., Mitchell, L., & Groen, HJ. (2013). Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: AVAPERL (MO22089). Journal of Clinical Oncology, 31(24), 3004-3011. https://doi.org/10.1200/jco.2012.42.3749

@article{57aed0e5d4d1429d8411e239d8aa9a65,

title = "Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: AVAPERL (MO22089)",

author = "F Barlesi and A Scherpenreel and A Rittmeyer and A Pazzola and {Ferrer Tur}, N and Jung-Ha Kim and MJ Ahn and Joachim Aerts and V Gorbunova and A Vikstrom and EK Wong and P Perez-Moreno and L Mitchell and HJ Groen",

year = "2013",

doi = "10.1200/jco.2012.42.3749",

language = "Undefined/Unknown",

volume = "31",

pages = "3004--3011",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "24",

}

Barlesi, F, Scherpenreel, A, Rittmeyer, A, Pazzola, A, Ferrer Tur, N, Kim, J-H, Ahn, MJ, Aerts, J, Gorbunova, V, Vikstrom, A, Wong, EK, Perez-Moreno, P, Mitchell, L & Groen, HJ 2013, 'Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: AVAPERL (MO22089)', Journal of Clinical Oncology, vol. 31, no. 24, pp. 3004-3011. https://doi.org/10.1200/jco.2012.42.3749

Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: AVAPERL (MO22089). / Barlesi, F; Scherpenreel, A; Rittmeyer, A et al.
In: Journal of Clinical Oncology, Vol. 31, No. 24, 2013, p. 3004-3011.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: AVAPERL (MO22089)

AU - Barlesi, F

AU - Scherpenreel, A

AU - Rittmeyer, A

AU - Pazzola, A

AU - Ferrer Tur, N

AU - Kim, Jung-Ha

AU - Ahn, MJ

AU - Aerts, Joachim

AU - Gorbunova, V

AU - Vikstrom, A

AU - Wong, EK

AU - Perez-Moreno, P

AU - Mitchell, L

AU - Groen, HJ

PY - 2013

Y1 - 2013

U2 - 10.1200/jco.2012.42.3749

DO - 10.1200/jco.2012.42.3749

M3 - Article

SN - 0732-183X

VL - 31

SP - 3004

EP - 3011

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 24

ER -

Barlesi F, Scherpenreel A, Rittmeyer A, Pazzola A, Ferrer Tur N, Kim J-H et al. Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: AVAPERL (MO22089). Journal of Clinical Oncology. 2013;31(24):3004-3011. doi: 10.1200/jco.2012.42.3749